DETON CORP

Medtech · Defunct

Coughlector device that captures airborne bacteria directly from patient cough for tuberculosis diagnosis

Grants
$450K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$225K
1 award · Health and Human S
#448 of 4531 in medtech
Patents
3
1 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Cough sample collection and processing for the diagnosis of pulmonary TB$224,981
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Cough sample collection and processing for the diagnosis of pulmonary TB$224,981
Federal contractDepartment of Health and Human Services · Igf::ot::igf Title - Cough Collector, A Non-invasive Device For Lower Respiratory Tract Droplet$224,999
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
445ASURAGEN, INC.$227K$13M
446HealthMyne, Inc.$225K$19M
447WINDTREE THERAPEUTICS, INC.$225K—
448DETON CORP$225K—
449NANOHYBRIDS INC$225K—
450XILIS INC$225K$109M
451PBS Biotech, Inc.$224K$43M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 3

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.